Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/2143
Title: Bronchodilator response in children using intra-breath oscillometry
Authors: Wong, M.
Sly, P.
Suresh, S.
Blake, T.
Issue Date: 2022
Source: 27, (SUPPL 1), 2022, p. 64
Pages: 64
Journal: Respirology
Abstract: Introduction/Aim: A bronchodilator response (BDR) is a test of reversible airway obstruction that can be used to define the presence of asthma. This study describes a BDR in children using intra-breath oscillometry (IB-Osc). Methods: Intra-breath respiratory impedance (IB-Zrs) was measured at baseline and 15 min after salbutamol 400 mcg using a single 10 Hz sinusoid in asymptomatic 7-year-old children participating in a community-based cohort study. IB-Zrs outcomes included resistance at end-expiration (ReE), resistance at end-inspiration (ReI), the volume dependence of resistance (ΔR = ReE-ReI), reactance at endexpiration (XeE), reactance at end-inspiration (XeI), and the volume dependence of reactance (ΔX = XeE-XeI). Absolute BDR was calculated as post-bronchodilator minus prebronchodilator value. Relative BDR was expressed as absolute BDR divided by the pre-bronchodilator value (as a percentage). Results: The feasibility of BDR testing was 93.7% (n = 74) including 40 females (54.1%). The mean (SD) absolute BDR for ReE and ReI was -1.28 (0.88) cmH2O.s.L-1 and -1.22 (0.83) cmH2O.s.L-1, respectively. The mean relative BDR for ReE and ReI was -20.28% (12.98) and -20.42% (11.50) respectively. The median (Q3, Q1) absolute BDR for ΔR was -0.04 (0.32, -0.37) cmH2O.s.L-1. The median absolute BDR for XeE and mean absolute BDR for XeI was 0.40 (0.77, 0.21) cmH2O.s.L-1 and 0.44 (0.50) cmH2O.s.L-1, respectively. The median relative BDR for XeE and XeI was 50.80% (18.75, 75.29) and 48.03% (14.95, 64.96) respectively. The median absolute BDR for ΔX was 0.04 (0.19, -0.18) cmH2O.s.L-1. There was no significant difference between children with asthma or wheezing in the last 12 months (n = 9) and healthy children (n = 65) in terms of baseline or BDR for IB-Zrs outcomes. Conclusion: The BDR measured by IB-Zrs was not significantly different in children with stable asthma compared to healthy children. Further studies of IB-Zrs involving intrasession testing variability and short-term repeatability in healthy children are required to better define a BDR.L6377948292022-04-25
DOI: 10.1111/resp.14216
Resources: https://www.embase.com/search/results?subaction=viewrecord&id=L637794829&from=exporthttp://dx.doi.org/10.1111/resp.14216 |
Keywords: cohort analysis;conference abstract;controlled study;feasibility study;female;human;major clinical study;airway resistance;school child;wheezing;bronchodilating agentsalbutamol;oscillometry;asthma;breathing;child
Type: Article
Appears in Sites:Children's Health Queensland Publications

Show full item record

Page view(s)

74
checked on Mar 13, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.